Literature DB >> 20038628

Single nucleotide polymorphism analysis of the major tripartite multidrug efflux pump of Escherichia coli: functional conservation in disparate animal reservoirs despite exposure to antimicrobial chemotherapy.

Christopher A Elkins1, Lisa B Mullis, David W Lacher, Carina M Jung.   

Abstract

AcrAB-TolC imparts a strong intrinsic resistance phenotype to many clinically significant molecules in Escherichia coli. This complex is composed of a pump, AcrB, and a periplasmic protein, AcrA, that exports substrates through a common outer membrane porin, TolC. A sequence survey of the pump-specific components, acrA and acrB, was conducted on three discrete animal reservoirs: rodents, bovines, and catfish. Although two of the reservoirs (bovine and catfish) were agrarian, and antibiotic use (ceftiofur and oxytetracycline/Romet 30, respectively) was reported for them, the vast majority of structural polymorphisms were silent except for T104A (AcrA) and Q733R (AcrB), found in certain bovine-derived strains. Overall, the genes were well conserved, with high ratios of synonymous to nonsynonymous substitutions (d(S)/d(N) ratios), consistent with or, in the case of acrB, better than those of standard multilocus sequence typing (MLST) loci. Furthermore, predicted recombination points from single nucleotide polymorphism (SNP) patterns in acrB support a modular evolution of transporter proteins, consistent with an ancient origin. However, functional studies with clones representing the major silent SNPs and the nonsilent mutation in acrB failed to generate significant differences in resistance to a range of common efflux pump substrates. Interestingly, a comparison between log-phase acrA and acrB expression profiles yielded inconsistent trends, with acrB expression increasing modestly (<1.8-fold) in many strains from the antibiotic-enriched pools. Our results suggest that structural polymorphisms in this major efflux pump system may not contribute significantly to adaptive resistance by altering function or substrate specificity but may have a potential use in improving phylogenetic relationships and/or source tracking.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20038628      PMCID: PMC2826003          DOI: 10.1128/AAC.01126-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  Alignment and structure prediction of divergent protein families: periplasmic and outer membrane proteins of bacterial efflux pumps.

Authors:  J M Johnson; G M Church
Journal:  J Mol Biol       Date:  1999-04-02       Impact factor: 5.469

2.  Structure of the periplasmic component of a bacterial drug efflux pump.

Authors:  Matthew K Higgins; Evert Bokma; Eva Koronakis; Colin Hughes; Vassilis Koronakis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-28       Impact factor: 11.205

3.  Molecular epidemiology of ceftiofur-resistant Escherichia coli isolates from dairy calves.

Authors:  Sarah C Donaldson; Beth A Straley; Narasimha V Hegde; Ashish A Sawant; Chitrita DebRoy; Bhushan M Jayarao
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

4.  Application of phylogenetic networks in evolutionary studies.

Authors:  Daniel H Huson; David Bryant
Journal:  Mol Biol Evol       Date:  2005-10-12       Impact factor: 16.240

5.  Automated phylogenetic detection of recombination using a genetic algorithm.

Authors:  Sergei L Kosakovsky Pond; David Posada; Michael B Gravenor; Christopher H Woelk; Simon D W Frost
Journal:  Mol Biol Evol       Date:  2006-07-03       Impact factor: 16.240

Review 6.  Modeling the tripartite drug efflux pump archetype: structural and functional studies of the macromolecular constituents reveal more than their names imply.

Authors:  C A Elkins; K E Beenken
Journal:  J Chemother       Date:  2005-12       Impact factor: 1.714

7.  A simple and robust statistical test for detecting the presence of recombination.

Authors:  Trevor C Bruen; Hervé Philippe; David Bryant
Journal:  Genetics       Date:  2006-02-19       Impact factor: 4.562

8.  A periplasmic drug-binding site of the AcrB multidrug efflux pump: a crystallographic and site-directed mutagenesis study.

Authors:  Edward W Yu; Julio R Aires; Gerry McDermott; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2005-10       Impact factor: 3.490

9.  The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis.

Authors:  Anthony M Buckley; Mark A Webber; Sue Cooles; Luke P Randall; Roberto M La Ragione; Martin J Woodward; Laura J V Piddock
Journal:  Cell Microbiol       Date:  2006-05       Impact factor: 3.715

10.  Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline.

Authors:  A M George; S B Levy
Journal:  J Bacteriol       Date:  1983-08       Impact factor: 3.490

View more
  7 in total

1.  Polyphenolic extract from maple syrup potentiates antibiotic susceptibility and reduces biofilm formation of pathogenic bacteria.

Authors:  Vimal B Maisuria; Zeinab Hosseinidoust; Nathalie Tufenkji
Journal:  Appl Environ Microbiol       Date:  2015-03-27       Impact factor: 4.792

2.  AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity.

Authors:  Jessica M A Blair; Vassiliy N Bavro; Vito Ricci; Niraj Modi; Pierpaolo Cacciotto; Ulrich Kleinekathӧfer; Paolo Ruggerone; Attilio V Vargiu; Alison J Baylay; Helen E Smith; Yvonne Brandon; David Galloway; Laura J V Piddock
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-03       Impact factor: 11.205

3.  A mecA-negative strain of methicillin-resistant Staphylococcus aureus with high-level β-lactam resistance contains mutations in three genes.

Authors:  Ritu Banerjee; Michael Gretes; Christopher Harlem; Li Basuino; Henry F Chambers
Journal:  Antimicrob Agents Chemother       Date:  2010-08-30       Impact factor: 5.191

4.  Analysis of AcrB in Klebsiella pneumoniae reveals natural variants promoting enhanced multidrug resistance.

Authors:  Ying Li; Trevor S Cross; Tobias Dörr
Journal:  Res Microbiol       Date:  2021-12-01       Impact factor: 3.946

5.  A scalable metabolite supplementation strategy against antibiotic resistant pathogen Chromobacterium violaceum induced by NAD+/NADH+ imbalance.

Authors:  Deepanwita Banerjee; Dharmeshkumar Parmar; Nivedita Bhattacharya; Avinash D Ghanate; Venkateswarlu Panchagnula; Anu Raghunathan
Journal:  BMC Syst Biol       Date:  2017-04-26

6.  Interactions of Polymyxin B in Combination with Aztreonam, Minocycline, Meropenem, and Rifampin against Escherichia coli Producing NDM and OXA-48-Group Carbapenemases.

Authors:  Marcus Hong; Hissa Al-Farsi; Anna Olsson; Christian G Giske; Pernilla Lagerbäck; Thomas Tängdén
Journal:  Antimicrob Agents Chemother       Date:  2021-09-13       Impact factor: 5.191

7.  Quantifying the Evolutionary Conservation of Genes Encoding Multidrug Efflux Pumps in the ESKAPE Pathogens To Identify Antimicrobial Drug Targets.

Authors:  Lauren E Brooks; Sabah Ul-Hasan; Benjamin K Chan; Mark J Sistrom
Journal:  mSystems       Date:  2018-04-17       Impact factor: 6.496

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.